Skip to main content

Table 1 Description of the study population, total as well as stratified for levels of hospitals

From: Two years’ experience of implementing a comprehensive telemedical stroke network comprising in mainly rural region: the Transregional Network for Stroke Intervention with Telemedicine (TRANSIT-Stroke)

  

total

level-I-hospitals

level-II/III-hospitals

p-value of levels

n = 7881

n = 927

n = 6954

age

       

<.0001

 years

mean (SD)

74.6

(12.8)

76.42

(12.2)

74.36

(12.9)

 

sex

       

0.0029

 male

n(%)

4070

(51.6)

436

(47.0)

3634

(52.3)

 

 female

n(%)

3811

(48.4)

491

(53.0)

3320

(47.7)

 

diagnosis

       

<.0001

 transient ischaemic attack

TIA

n(%)

1938

(24.6)

334

(36.0)

1604

(23.1)

 

 ischaemic stroke

IS

n(%)

5409

(68.6)

527

(56.9)

4882

(70.2)

 

 haemorrhagic stroke

HS

n(%)

504

(6.4)

44

(4.8)

460

(6.6)

 

 undefined stroke

US

n(%)

30

(0.4)

22

(2.4)

8

(0.1)

 

treatment

#lyse iv

n(%)

1113

(20.6)

50

(9.5)

1063

(21.8)

<.0001

#lyse ia

n(%)

68

(1.3)

1

(0.2)

67

(1.4)

0.0206

#thrombectomy

n(%)

226

(4.2)

2

(0.4)

224

(4.6)

<.0001

 ventilation

n(%)

378

(4.8)

25

(2.7)

353

(5.1)

0.0014

diagnostics

 dysphagia screening

n(%)

6895

(87.5)

396

(42.7)

6499

(93.5)

<.0001

 long-term ECG

n(%)

7206

(91.4)

844

(91.1)

6362

(91.5)

0.6134

 extracranial

n(%)

7457

(94.6)

780

(84.1)

6677

(96.0)

<.0001

  < 48 h

n(%)

7003

(88.9)

583

(62.9)

6420

(92.3)

 

  > = 48 h

n(%)

454

(5.8)

197

(21.3)

257

(3.7)

 

 intracranial

n(%)

7223

(91.7)

571

(61.6)

6652

(95.7)

<.0001

  < 48 h

n(%)

6939

(88.1)

548

(59.1)

6391

(91.9)

 

  > = 48 h

n(%)

284

(3.6)

23

(2.5)

261

(3.8)

 

NIHSS – at admission

       

0.0290

 

median (IQR)

3

(1–7)

3

(1–6)

3

(1–7)

 

 0

n(%)

1343

(17.1)

168

(18.1)

1175

(16.9)

 

 1–4

n(%)

3643

(46.2)

406

(43.8)

3237

(46.6)

 

 5–15

n(%)

2227

(28.3)

289

(31.2)

1938

(27.89)

 

 16–20

n(%)

371

(4.7)

29

(3.1)

342

(4.9)

 

 21–42

n(%)

294

(3.7)

35

(3.8)

259

(3.7)

 

mRS – at admission

 

median (IQR)

3

(1–4)

3

(1–4)

3

(1–4)

 

 0–1

n(%)

2191

(27.8)

267

(28.8)

1924

(27.7)

0.4751

 2–6

n(%)

5686

(72.2)

660

(71.2)

5026

(72.3)

 

 0–2

n(%)

3809

(48.4)

454

(49.0)

3355

(48.3)

0.6880

 3–6

n(%)

4068

(51.6)

473

(51.0)

3595

(51.7)

 

mRS – at discharge

 

median (IQR)

2

(0–3)

2

(0–3)

2

(0–3)

 

 0–1

n(%)

3616

(45.9)

453

(48.9)

3163

(45.5)

0.0550

 2–6

n(%)

4259

(54.0)

474

(51.1)

3785

(54.5)

 

 0–2

n(%)

5170

(65.7)

670

(72.3)

4500

(64.8)

<.0001

 3–6

n(%)

2705

(34.4)

257

(27.7)

2448

(35.2)

 

Barthel Index – at admission

      

0.0003

 

mean (SD)

62.50

(35.1)

60.81

(34.3)

62.72

(35.2)

 
 

median (IQR)

75.00

(37.5–100)

52.50

(37.5–100)

75.00

(37.5–100)

 

Barthel Index – at discharge

      

<.0001

 

mean (SD)

73.28

(32.7)

75.07

(29.8)

73.05

(33.1)

 
 

median (IQR)

87.50

(50.5–100)

87.50

(62.5–100)

87.50

(50–100)

 

Comorbidities

 diabetes

n(%)

2038

(25.9)

255

(27.5)

1783

(25.6)

0.2243

 hyper tonus

n(%)

6798

(86.3)

805

(86.8)

5993

(86.2)

0.5983

 atrial fibrillation

n(%)

2301

(29.2)

263

(28.4)

2038

(29.3)

0.8371

 previous stroke

n(%)

2269

(28.8)

238

(25.7)

2031

(29.2)

0.0253

onset-to-door-time

      

<.0001

 < =1 h

n(%)

892

(11.3)

63

(6.8)

829

(11.9)

 

 1-2 h

n(%)

1436

(18.2)

144

(15.5)

1292

(18.6)

 

 2-3 h

n(%)

780

(9.9)

94

(10.1)

686

(9.9)

 

 3-3.5 h

n(%)

257

(3.3)

48

(5.2)

209

(3.0)

 

 3.5-4 h

n(%)

238

(3.0)

34

(3.7)

204

(2.9)

 

 4-6 h

n(%)

562

(7.1)

77

(8.3)

485

(7.0)

 

 6-24 h

n(%)

1383

(17.6)

189

(20.4)

1194

(17.2)

 

 24-48 h

n(%)

564

(7.12)

85

(9.2)

479

(6.9)

 

 > 48 h

n(%)

812

(10.3)

58

(6.3)

754

(10.9)

 

 unknown

n(%)

953

(12.1)

135

(14.6)

818

(11.8)

 

#door-to-needle-time

      

<.0001

 < =30 min

n(%)

619

(11.5)

4

(0.8)

615

(12.6)

 

 30-60 min

n(%)

409

(7.6)

29

(5.5)

380

(7.8)

 

 > 60 min

n(%)

147

(2.7)

17

(3.2)

130

(2.7)

 

 no lysis applied

n(%)

4232

(78.3)

477

(90.5)

3755

(77.0)

 

length of stay

      

0.1129

 days

mean (SD)

8.5

(6.3)

8.8

(6.4)

8.4

(6.3)

 

secondary prevention

       

 anticoagulation

n(%)

1999

(25.4)

244

(26.3)

1755

(25.2)

0.4836

  VitKAnt

n(%)

923

(11.7)

130

(14.0)

793

(11.4)

 

  NOAK

n(%)

1076

(13.7)

114

(12.3)

962

(13.8)

 

 statins

n(%)

5827

(73.9)

763

(82.3)

5064

(72.8)

<.0001

 IPA within 48 h

n(%)

6053

(76.8)

770

(83.1)

5283

(76.0)

<.0001

 IPA at discharge

n(%)

5534

(70.2)

673

(72.6)

4861

(69.9)

0.0281

in-hospital mortality

      

0.4158

 

n(%)

423

(5.4)

55

(5.9)

568

(5.3)

 

reason of discharge

      

<.0001

 end of treatment as scheduled

n(%)

4938

(62.9)

729

(78.6)

4209

(60.6)

 

 end of treatment due to other reason

n(%)

123

(1.6)

14

(1.5)

109

(1.6)

 

 transfer to other hospital

n(%)

477

(6.1)

46

(5.0)

431

(6.2)

 

 transfer to acute rehabilitation

n(%)

1358

(17.2)

68

(7.3)

1290

(18.6)

 

 transfer to skilled nursing facility

n(%)

455

(5.8)

13

(1.4)

442

(6.4)

 

 transfer to other department

n(%)

107

(1.4)

2

(0.2)

105

(1.5)

 

 death

n(%)

420

(5.3)

55

(5.9)

365

(5.3)

 
  1. # as basis only ischaemic stroke is taken, i.e. 5409 = 527 + 4882